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Abstract
Aim To describe mood and psychosensorial symptoms of hypoglycaemia in adolescents with Type 1 diabetes mellitus
in two countries with different cultures, Turkey and the USA.
Methods We developed a 68-item questionnaire assessing physical, behavioural, mood and psychosensorial symptom
frequency and ratings [‘good’, ‘bad’, or ‘both’ (sometimes good, sometimes bad)]. Adolescents with Type 1 diabetes were
recruited from paediatric diabetes clinics at the University of North Carolina at Chapel Hill in the USA and Kocaeli
University in Turkey. The percentages of participants at each clinic who endorsed individual symptoms, symptom
categories and symptom ratings were calculated and compared.
Results Cronbach’s a values were > 0.7 for each real symptom category. No symptom items were excluded from the
questionnaire analysis based on item-total correlation results which were all > 0.2. Data were collected from 132
participants (69 from University of North Carolina, 63 from Kocaeli University, 54% male). The mean (SD) age of the
participants was 14.9 (1.9) years, HbA1c level was 8.7 (1.8) % and duration of Type 1 diabetes was 5.8 (3.7) years. On
average, each physical symptom was experienced by 65.2% of participants, each behavioural symptom by 46.5%, each
mood symptom by 42.8%, and each psychosensorial symptom by 48.9%. On average, each physical, behavioral, mood
and psychosensorial symptom was rated as ‘good’ or ‘both’ by 23.0, 29.1, 36.9 and 37.2% of participants, respectively.
There were no symptom differences between the groups in each country.
Conclusions In addition to the classic physical symptoms experienced during hypoglycaemia, adolescents with Type 1
diabetes report psychosensorial, mood and behavioral symptoms, and some describe them as positive experiences.
Symptom experiences were similar in these two countries with different cultures.
Diabet. Med. 31, 1245–1251 (2014)
Introduction
Hypoglycaemia is a well-known complication of Type 1
diabetes mellitus treatment that can lead to seizure, coma,
long-term neurocognitive sequelae and even death. Individ-
uals with Type 1 diabetes experience ~2 episodes of
symptomatic hypoglycaemia per week [1]. Severe hypoglyca-
emia (requiring help for recovery) has an annual prevalence
of 30–40% among people with Type 1 diabetes and an
annual incidence of 1.0–1.7 episodes per patient per year for
all people with Type 1 diabetes. Since hypoglycaemia is so
commonly experienced, early recognition of the symptoms is
essential to prevent severe complications.
Aside from the traditionally recognized symptoms of
hypoglycaemia (e.g. neuroglycopenic, autonomic and mal-
aise symptoms) [2], some adults with Type 1 diabetes report
both negative and positive mood changes [3–6] and, in
children, hypoglycaemia may be manifested in behavioural
changes [7,8]. Both adults and adolescents have been
reported to experience pleasurable symptoms and symptoms
of being ‘high’ [9–14], but these symptoms have never been
scientifically studied before. Feelings of being ‘high’ may be
explained by the psychosensorial experiences of derealization
(distortion in how the immediate environment is perceived)
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and depersonalization (distortion in how one’s own body
and subjective self feel). These symptoms may contribute to
episodes being perceived as positive, even desirable, rather
than negative and potentially dangerous. Few paediatric
studies have described the physical, mood and behavioural
symptoms associated with hypoglycaemia and none have
described psychosensorial experiences.
The aim of the present study was to broaden the
understanding of hypoglycaemic symptoms in adolescents
with Type 1 diabetes by describing self-reported psychosen-
sorial symptoms as well as the physical, behavioural and
mood symptoms of hypoglycaemia. We further sought to
examine whether these symptoms were rated as ‘good’ (i.e.
positive), ‘bad’ (i.e. negative), or ‘both’ (i.e. sometimes good
and sometimes bad) by the participants. Taking advantage of
the relationship of one of the present authors with the
paediatric endocrinology clinics at both the University of
North Carolina at Chapel Hill, Chapel Hill, NC, USA and
Kocaeli University, Kocaeli, Turkey, we also decided to




A 68-item questionnaire was developed to assess previous
experiences with hypoglycaemia. The first item asked
participants to report at what blood glucose level they
typically ‘begin to feel low’ and the remaining 67 items were
possible symptoms divided into five different categories:
physical (19 items); behavioural (five items); mood (17
items); and psychosensorial (19 items), as well as a dummy
category (seven items). The physical and behavioural symp-
toms were assembled from those described previously in the
paediatric literature [7,8] and mood symptoms consisted of a
compiled list of conventionally perceived negative (e.g.
‘mean’) and positive (e.g. ‘silly’) emotions. Psychosensorial
items were based on studies on panic disorders and substance
abuse [15,16]. Dummy items were symptoms that are not
thought to be associated with hypoglycaemia (e.g. rash), and
were used to assess the integrity of each participant’s
responses. Dummy items were used to exclude any partici-
pant who endorsed all dummy items because of concern
about the credibility of participants’ answers.
A five-point Likert scale was used to assess the frequency at
which each symptom had ever been experienced (0 = never, 1
= rarely, 2 = sometimes, 3 = often, 4 = always); that is,
participants would indicate that during hypoglycaemic
events they never, rarely, sometimes, often, or always
experienced a particular symptom. Participants who ever
experienced a symptom (Likert score 1, 2, 3 or 4) were then
asked to rate the symptom experience as ‘good,’ ‘bad,’ or
‘both’ (sometimes good, sometimes bad). At the completion
of data collection, the Likert scale was condensed into two
categories to improve statistical power: ever experienced a
symptom vs never experienced a symptom (Likert score 0 vs
1, 2, 3 or 4).
The face and content validity of the questionnaire was
examined by a panel of experts including paediatric endo-
crinologists, child psychologists and a survey methodologist,
who reviewed the questionnaire content and construct.
Item-total correlation was calculated to further examine
survey construct. An item-total correlation > 0.2 was
considered acceptable. Cronbach’s a values for each symp-
tom category were calculated to validate the questionnaire
and assess whether the symptoms in each category measured
similar concepts. An a value > 0.7 was considered acceptable.
The survey was first developed in the English language and
then translated into Turkish by a paediatric endocrinologist
and child psychologist fluent in both English and Turkish.
Forward and backward translations were used to assess the
accuracy of the language translation. During the first 2 weeks
of the study, participants were asked if they had any
difficulty understanding or answering the questionnaire after
completing it, to assess the appropriateness of the language
used as well as the ease of questionnaire completion; no
difficulties were reported.
Participants
Children were eligible to participate if they: 1) had Type 1
diabetes for at least 6 months (to increase the likelihood that
they had experienced hypoglycaemia); 2) were 12–18 years
old (children aged <12 years may not be able to indepen-
dently describe their hypoglycaemia symptoms as well as
older children); and 3) received care from diabetes clinics at
University of North Carolina or Kocaeli University. We
invited 134 consecutive patients who met the eligibility
criteria to participate during routine visits between February
2010 and June 2010. Of these, 133 participants and their
parent/guardian provided written informed consent and
completed the questionnaire anonymously and privately
without parents in the room. The study was approved by
What’s new?
● There are multiple cases of people reportedly feeling
‘high’ during hypoglycaemia, which may be explained
by psychosensorial symptoms (alterations in how one’s
environment and subjective self are perceived). This is
the first study of psychosensorial symptoms during
hypoglycaemia in adolescents with Type 1 diabetes
● Psychosensorial symptoms are common and are often
reported as positive experiences during hypoglycaemia.
● There were no differences in how hypoglycaemia
symptoms were reported in adolescents from two
countries with different cultures.
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the institutional review boards of the University of North
Carolina and Kocaeli University.
Medical record review
Medical records were reviewed to obtain demographic
information including age, gender, duration of diabetes,
and HbA1c level at the time of study participation.
Data analysis
Demographic and clinical data from the time of study
participation are reported as percentages or mean (SD) values
for gender, age, HbA1c level at the study visit, duration of
diabetes and reported blood glucose level at which the
patients begin feeling hypoglycaemic. We used t-tests to
compare continuous variables and chi-squared tests to
compare proportions for categorical variables.
Next, the percentage of participants who experienced each
symptom was calculated, and a mean percentage of partic-
ipants reporting symptoms was calculated for each symptom
category. Similarly, the percentage of participants who rated
a symptom (having reportedly experienced the symptom) as
‘good,’ ‘bad,’ or ‘both’ was calculated, and a mean percent-
age of participants was calculated for each category rating.
To determine what percentage of participants endorsed the
symptoms as ever being a positive experience, the percentage
of participants that described symptoms as ‘good’ or ‘both’
was also calculated. To compare the ratings between
symptom categories, a mixed-effects logistic regression
model was used in order to avoid over-dispersion of a
sequence of binary outcomes within the same symptom
category by a participant. The odds ratio and its 0.95 CI
were calculated based on the coefficient estimation and its
Wald-type coverage in the logistic model.
Results at each site were analysed for differences using
t-tests for continuous variables and chi-squared tests for
categorical variables, and the results of the sites were
combined after determining that there were no differences
between sites for symptom category endorsements or
ratings.
All statistical tests were two-tailed with an a value of 0.05
significance level. R software (R Development Core Team,
Vienna, Austria) and IBM SPSS v. 19 (SPSS Inc., Chicago, IL,
USA) were the statistical packages used for analyses.
Results
Cronbach’s a values were > 0.7 for each symptom category
except for the dummy items, demonstrating the reliability
with which each real symptom category measured similar
concepts (physical 0.81, behavioural 0.78, mood 0.82,
psychosensorial 0.89, dummy 0.60). No symptom items
were excluded from the questionnaire analysis based on
item-total correlation results which were all > 0.2.
Of the 133 eligible and consenting participants, one
participant’s results were excluded from analysis because of
having endorsed all dummy items, leaving a total sample size
of 132 participants, 69 from the University of North
Carolina and 63 from Kocaeli University. The study popu-
lations included slightly more boys (54%) than girls, and the
mean (SD) age of the participants was 14.9 (1.9) years
(Table 1). The sites differed with regard to duration of
diabetes, mean HbA1c level and blood glucose level at which
symptoms began, such that participants at University of
North Carolina had a higher mean HbA1c level, a higher
mean reported blood glucose level at which symptoms began
and longer duration of diabetes at the time of study
participation.
In examining the percentage of participants who ever
experienced the symptoms presented in the questionnaire (i.e.
reported a Likert score indicating ‘rarely’ to ‘always’), we
found that the most commonly reported symptom category
was physical, with a mean of 65.2% of participants reporting
each symptom (Table 2). The physical symptoms experi-
enced by the most participants were trembling, weakness,
feeling run down, headache and feeling ‘awful’. Psychosen-
sorial symptoms (depersonalization and derealization) were
experienced on average by 48.9% of participants, and the
most experienced symptoms were difficulty concentrating,
lightheadedness, confusion, feeling ‘spaced out’, and ‘feeling
like you don’t care’. A mean of 46.5% of participants
reported behavioural symptoms. The most frequently expe-
rienced behavioural symptoms were odd behaviour, argu-
mentativeness and aggressiveness. Mood symptoms were
experienced by a mean of 42.8% of participants. The most
experienced mood symptoms were jitteriness, unhappiness,
edginess, uneasiness, and moodiness/feeling as though on an
emotional roller coaster.
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Generally, symptoms were reported as ‘good’ or ‘both’ by
one-quarter to one-third of the participants. Of participants
who ever experienced physical symptoms, 23.1% reported
them as ‘good’ or ‘both’. The physical symptoms most
commonly reported as ‘good’ or ‘both’ were yawning,
sleepiness, warmness, tiredness and restlessness. Of partici-
pants who ever experienced behavioural symptoms, 29.2%
reported them as ‘good’ or ‘both’. The behavioural symp-
toms most commonly reported as ‘good’ or ‘both’ were
naughtiness, meanness and odd behaviour. Of participants
who ever experienced mood symptoms, 36.9% reported
them as ‘good’ or ‘both’. The mood symptoms most
commonly reported as ‘good’ or ‘both’ were feeling jolly/
silly, cheerful, revved up, full/rush of energy and excited. The
psychosensorial symptom category had the most positive
responses, with 37.2% of participants reporting the symp-
toms as ‘good’ or ‘both’. The psychosensorial symptoms
most commonly reported as ‘good’ or ‘both’ were dreaming,
feeling free/having let go of self, mellow/chilled out, alert and
floating/moving through the world differently. The psycho-
sensorial and mood categories had the highest odds of
positive endorsement compared with other symptom catego-
ries [psychosensorial compared with physical: odds ratio 2.8
(95% CI 2.3, 3.4); psychosensorial compared with behavio-
ural: odds ratio 1.7 (95% CI 1.2, 2.3); psychosensorial
compared with mood: odds ratio 1.1 (95% CI 0.9, 1.4);
mood compared with physical: odds ratio 2.5 (95% CI 2.1,
3.1); and mood compared with behavioural: odds ratio: 1.5
(95% CI 1.1, 2.1)]. The symptoms according to frequency
and ratings for mood and psychosensorial categories are
shown in Figs 1 and 2, respectively.
There was no statistically significant relationship for any
symptom category endorsement frequency or ratings
with study location, age, gender, HbA1c level, reported
blood glucose level at which hypoglycaemia symptoms begin,
or duration of Type 1 diabetes at the time of study
participation.
Discussion
As anticipated, we found that adolescents commonly expe-
rience physical and behavioural symptoms during hypo-
glycaemia, but this is the first study to report that many
adolescents with Type 1 diabetes also experience psychosen-
sorial symptoms of depersonalization and derealization and
mood changes during hypoglycaemia. Surprisingly, hypo-
glycaemia symptoms are also sometimes described as positive
experiences, particularly the psychosensorial and mood
symptoms. The reported symptom experiences were similar
in both the University of North Carolina and Kocaeli
University samples, suggesting no difference between these
two cultural settings.





category Psychosensorial category Dummy category
Overall 65.2 Overall 46.5 Overall 42.8 Overall 48.9 Overall 10.5
Trembling 95.7 Odd behaviour 62.0 Jittery 68.8 Difficulty concentrating 79.9 Pain in joints 20.3
Weak 88.3 Argumentativeness 60.0 Unhappy 62.1 Lightheaded 78.4 Runny nose 12.1
Run down 86.1 Aggressiveness 54.0 Edgy 59.1 Confused 70.1 Itchy 10.9
Feeling awful 84.3 Meanness 39.4 Uneasy 54.7 Spaced out 62.8 Sneezing 9.5
Sweating 83.2 Naughtiness 17.3 Agitated 52.6 Just don’t care
about things
60.1 Stuffy nose 9.4
Tired 82.5 Moody/Emotional
roller coaster
52.6 Things feel different 55.1 Cough 8.7
Sleepy 78.4 Irritable 49.6 Dazed/In a fog 51.4 Rash 2.2
Uncoordinated 77.9 Gloomy 49.6 Loosened up 45.3
Dizziness 76.3 Calm 46.4 Things look different
than normal
45.3
Restless 60.4 Aggravated 46.3 Buzzed 42.1
Sick 59.4 Sorrowful/Sad 37.8 Things sound different
than normal
41.6
Pounding heart 59.0 Jolly/Silly 34.5 Floating/Moving through
the world differently
41.0
Blurred vision 58.3 Excited 31.4 Free/Having let go from
normal self
41.0
Headache 57.1 Full/Rush of
energy
30.0 World slightly strange/
unreal
39.9
Warmness 55.1 Cheerful 19.0 Outside of body 38.4
Slurred speech 40.6 Revved up 17.5 Mellow/Chilled out 38.0
Yawning 40.3 Elated 14.9 Distant/Separate from
real world
36.8
Tingling lips 33.1 Daydreaming 34.8
Tummy pain 22.6 Alert 26.6
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The present findings are supported by adult studies
evaluating mood symptoms of hypoglycaemia, which have
shown that low blood glucose is often associated with
negative mood states, but also occasionally with positive
mood states [1,17–19]. There have also been case reports of
adults and adolescents who misuse insulin to achieve a
euphoric or ‘high’ effect [7,8,14,20–22]. In a study by
Schober et al. [14], 35% of adolescents who overdosed with
insulin reported that feeling ‘high’ during hypoglycaemia was
one of the reasons for their actions, in addition to suicidal
intentions or attention seeking; therefore, we believe the



























































FIGURE 2 Percentage of participants reporting psychosensorial symptoms and how these symptoms were rated.
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and psychosensorial symptoms, in addition to the well--
known physical and behavioural symptoms of hypoglyca-
emia, and that these symptoms are sometimes positively
experienced are valid.
Limitations of the present study include its relatively small
sample size and reliance on recall of previous hypoglycaemic
experiences. In addition, we were not able to report the
frequency with which participants experienced hypoglyca-
emia. Nevetheless, based on the present work, further studies
can now be designed in the knowledge that some adolescents
endorse psychosensorial symptoms and that hypoglycaemia
symptoms are sometimes reported as good. In addition, while
our questionnaire categories demonstrated excellent internal
consistency, as evidenced by high Cronbach’s a values,
further validation techniques would be needed before appli-
cation to other populations.
Hypoglycaemia is known to cause a considerable burden
to families of children with diabetes through increased
anxiety, poor sleep and a high number of hospitalizations,
while also leading to excessive lowering of insulin doses and
worsening glycaemic control [21]. Prompt hypoglycaemia
symptom recognition is important for reducing diabe-
tes-associated morbidity and mortality such as the hypo-
glycaemia-associated decrease in neurocognitive function
and structural brain changes found in some studies in young
children with Type 1 diabetes [17–20,23,24]. Considering
that negative symptoms of hypoglycaemia have been the
focus of traditional diabetes education and that positive
symptoms are likely to be more desirable and better
tolerated, it is possible that some hypoglycaemia unaware-
ness may be attributable to predominantly positive hypogly-
caemic experiences that are not being recognized as possible
symptoms of hypoglycaemia. An understanding of the array
of hypoglycaemia symptoms reported in the present study,
therefore, may help providers educate patients and their
families regarding the variety of possible symptoms, includ-
ing the potential for positive experiences. In turn, children
with diabetes and their families may improve their recogni-
tion of hypoglycaemia, which could lead to faster treatment
and prevention of complications.
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